Sample Page
Author:
Gain Therapeutics, Inc.
Posted Date:
May 11, 2026
Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update
Gain Therapeutics, Inc.
May 11, 2026
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
Gain Therapeutics, Inc.
April 24, 2026
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
Gain Therapeutics, Inc.
March 26, 2026
Gain Therapeutics to Present at the 38th Annual ROTH Conference
Gain Therapeutics, Inc.
March 19, 2026
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
Gain Therapeutics, Inc.
March 18, 2026
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
Gain Therapeutics, Inc.
March 12, 2026
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Gain Therapeutics, Inc.
February 19, 2026
